Guy Vigers

7.3k total citations
41 papers, 2.1k citations indexed

About

Guy Vigers is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Guy Vigers has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Computational Theory and Mathematics. Recurrent topics in Guy Vigers's work include Protein Kinase Regulation and GTPase Signaling (12 papers), Melanoma and MAPK Pathways (9 papers) and Computational Drug Discovery Methods (7 papers). Guy Vigers is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (12 papers), Melanoma and MAPK Pathways (9 papers) and Computational Drug Discovery Methods (7 papers). Guy Vigers collaborates with scholars based in United States and United Kingdom. Guy Vigers's co-authors include Barbara J. Brandhuber, Manfred J. Lohka, R.A. Crowther, Barbara M. F. Pearse, J. Richard McIntosh, Wen‐I Wu, Lana J. Anderson, W.C. Voegtli, Hillary L. Sturgis and James P. Rizzi and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Guy Vigers

41 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy Vigers United States 23 1.4k 547 349 276 203 41 2.1k
Kuo‐Sen Huang United States 26 2.0k 1.4× 384 0.7× 262 0.8× 209 0.8× 116 0.6× 45 3.1k
Ingrid Remy Canada 14 1.6k 1.1× 388 0.7× 207 0.6× 127 0.5× 87 0.4× 15 2.2k
Andrew J. Massey United Kingdom 24 1.5k 1.1× 250 0.5× 205 0.6× 227 0.8× 339 1.7× 43 2.0k
P. Dokurno United Kingdom 18 1.3k 0.9× 400 0.7× 182 0.5× 262 0.9× 129 0.6× 38 1.7k
Stephen W. Michnick Canada 26 2.6k 1.8× 608 1.1× 169 0.5× 240 0.9× 220 1.1× 41 3.1k
Bertram Canagarajah United States 16 2.0k 1.4× 530 1.0× 167 0.5× 176 0.6× 192 0.9× 21 2.4k
Jérémie Vendôme United States 21 1.4k 1.0× 643 1.2× 157 0.4× 124 0.4× 110 0.5× 31 2.0k
Dirk Eberhard Germany 15 1.5k 1.1× 173 0.3× 194 0.6× 132 0.5× 172 0.8× 19 2.1k
D.T. Gewirth United States 27 2.1k 1.5× 492 0.9× 481 1.4× 67 0.2× 318 1.6× 43 2.7k
Julie A. Tucker United Kingdom 28 1.6k 1.1× 213 0.4× 193 0.6× 407 1.5× 245 1.2× 43 2.3k

Countries citing papers authored by Guy Vigers

Since Specialization
Citations

This map shows the geographic impact of Guy Vigers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Vigers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Vigers more than expected).

Fields of papers citing papers by Guy Vigers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Vigers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Vigers. The network helps show where Guy Vigers may publish in the future.

Co-authorship network of co-authors of Guy Vigers

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Vigers. A scholar is included among the top collaborators of Guy Vigers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Vigers. Guy Vigers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, David N. M., Laurel M. Pegram, Guy Vigers, et al.. (2024). Conformation selection by ATP-competitive inhibitors and allosteric communication in ERK2. eLife. 12. 5 indexed citations
2.
Jones, David N. M., Laurel M. Pegram, Guy Vigers, et al.. (2023). Conformation selection by ATP-competitive inhibitors and allosteric communication in ERK2. eLife. 12. 4 indexed citations
3.
Pegram, Laurel M., Jennifer Liddle, Yao Xiao, et al.. (2019). Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2. Proceedings of the National Academy of Sciences. 116(31). 15463–15468. 31 indexed citations
4.
Brandhuber, Barbara J., Nisha Nanda, Julia Haas, et al.. (2015). Abstract B192: Identification and characterization of highly potent and selective RET kinase inhibitors for the treatment of RET-driven cancers. Molecular Cancer Therapeutics. 14(12_Supplement_2). B192–B192. 5 indexed citations
5.
Volgraf, Matthew, Lina Chan, Malcolm P. Huestis, et al.. (2014). Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(11). 2477–2480. 9 indexed citations
6.
Wenglowsky, Steve, Li Ren, Jonas Grina, et al.. (2014). Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-RafV600E kinase. Bioorganic & Medicinal Chemistry Letters. 24(8). 1923–1927. 16 indexed citations
7.
Kallan, Nicholas C., Keith L. Spencer, James F. Blake, et al.. (2011). Discovery and SAR of spirochromane Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(8). 2410–2414. 33 indexed citations
8.
Xu, Rui, James F. Blake, Ian S. Mitchell, et al.. (2011). Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA. Bioorganic & Medicinal Chemistry Letters. 21(8). 2335–2340. 10 indexed citations
9.
Hansen, Joshua D., Jonas Grina, M. Bruce Welch, et al.. (2010). Non-oxime pyrazole based inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 21(11). 3488–3492. 38 indexed citations
10.
Ren, Li, Ellen R. Laird, Steve Wenglowsky, et al.. (2010). The Discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(4). 1248–1252. 22 indexed citations
11.
Wu, Wen‐I, et al.. (2010). Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition. PLoS ONE. 5(9). e12913–e12913. 258 indexed citations
12.
Bencsik, Josef R., Dengming Xiao, James F. Blake, et al.. (2010). Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(23). 7037–7041. 29 indexed citations
13.
Blake, James F., Nicholas C. Kallan, Dengming Xiao, et al.. (2010). Discovery of pyrrolopyrimidine inhibitors of Akt. Bioorganic & Medicinal Chemistry Letters. 20(19). 5607–5612. 46 indexed citations
14.
Ren, Li, Steve Wenglowsky, Stephen T. Schlachter, et al.. (2010). Non-oxime inhibitors of B-RafV600E kinase. Bioorganic & Medicinal Chemistry Letters. 21(4). 1243–1247. 26 indexed citations
15.
Hansen, Joshua D., Jonas Grina, Brad Newhouse, et al.. (2008). Potent and selective pyrazole-based inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 18(16). 4692–4695. 57 indexed citations
16.
Vigers, Guy, David J. Dripps, Carl K. Edwards, & Barbara J. Brandhuber. (2000). X-ray Crystal Structure of a Small Antagonist Peptide Bound to Interleukin-1 Receptor Type 1. Journal of Biological Chemistry. 275(47). 36927–36933. 49 indexed citations
17.
Vigers, Guy, et al.. (1997). Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1β. Nature. 386(6621). 190–194. 222 indexed citations
18.
Evans, R J, John D. Childs, Guy Vigers, et al.. (1995). Mapping Receptor Binding Sites in Interleukin (IL)-1 Receptor Antagonist and IL-1β by Site-directed Mutagenesis. Journal of Biological Chemistry. 270(19). 11477–11483. 83 indexed citations
19.
Vigers, Guy & Manfred J. Lohka. (1991). A distinct vesicle population targets membranes and pore complexes to the nuclear envelope in Xenopus eggs.. The Journal of Cell Biology. 112(4). 545–556. 132 indexed citations
20.
Vigers, Guy, et al.. (1986). Electron microscopy of frozen-hydrated biological material. Nature. 320(6063). 638–638. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kuo‐Sen Huang Breakdown of academic impact, for papers by Ingrid Remy Breakdown of academic impact, for papers by Andrew J. Massey Breakdown of academic impact, for papers by P. Dokurno Breakdown of academic impact, for papers by Stephen W. Michnick Breakdown of academic impact, for papers by Bertram Canagarajah Breakdown of academic impact, for papers by Jérémie Vendôme Breakdown of academic impact, for papers by Dirk Eberhard Breakdown of academic impact, for papers by D.T. Gewirth Breakdown of academic impact, for papers by Julie A. Tucker
Rankless by CCL
2026